Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Limited utility of fluorescence<i>in situ</i>hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms

22 Jul 2013

Abstract excerpt

Fluorescence in situ hybridization for abnormalities common to myelodysplastic syndrome (MDS FISH) is often used with traditional karyotype in the diagnosis and monitoring of myeloid neoplasms. However, its value in these roles has been questioned. To evaluate its utility, we compared MDS FISH results with karyotype in 544 bone marrow specimens obtained for diagnosis (180 cases) or follow-up (364 cases) of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Hematological disorders and diagnostics
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23876099
DOI: 10.3109/10428194.2013.801470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Limited utility of fluorescence<i>in situ</i>hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasmsPMID 23876099Read ↗

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?Semantic proximity Read ↗

The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failureSemantic proximity Read ↗

FISH analysis in addition to G-band karyotyping: Utility in evaluation of myelodysplastic syndromes?Semantic proximity Read ↗

Primary myelodysplastic syndrome with normal cytogenetics: utility of ‘FISH panel testing’ and M-FISHSemantic proximity Read ↗

Myelodysplastic Syndromes Arising in Patients With Germline <i>TP53</i> Mutation and Li-Fraumeni SyndromeSemantic proximity Read ↗

Fluorescence In Situ Hybridization Testing for −5/5q, −7/7q, +8, and del(20q) in Primary Myelodysplastic Syndrome Correlates With Conventional Cytogenetics in the Setting of an Adequate StudySemantic proximity Read ↗

FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patientsSemantic proximity Read ↗

Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patientsSemantic proximity Read ↗

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.